During the past decade, Complejo Hospitalario de Jaen conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 35 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 26 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario de Jaen" #1 sponsor was "Spanish Breast Cancer Research Group" with 21 trials, followed by "Pfizer" with 9 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "PETHEMA Foundation" with 6 trials sponsored and "Fundación GECP" with 6 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Jaen" #1 collaborator was "Hoffmann-La Roche" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Jaen" are "Breast Cancer" (22 trials), "Breast Neoplasms" (6 trials), "Metastatic Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (4 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Complejo Hospitalario de Jaen" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Jaen" are "Drug" (83 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (11 trials), "Carboplatin" (10 trials), "Docetaxel" (9 trials), "Placebo" (9 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Jaen" are 79 trials for "All" genders, 32 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Jaen". 1 are not yet recruiting, 17 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in Complejo Hospitalario de Jaen, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Jaen, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 2 trials that are defined as “Not Applicable".